An unusual cause of gastric extraluminal compression: fibrolamellar hepatocellular carcinoma

Salvatore Dilettoso 1 , Mario Uccello 2 , Alessandra Dilettoso 1 , Salvatore Gelardi 1 , and Benedetto Dilettoso 1
  • 1 ASP 3 Catania, Radiology Operative Unit, SS Salvatore Hospital, Via Livorno 1, I-95047, Paternò, Italy
  • 2 Department of Biomedical Sciences, University of Catania, Via Androne 83, I-95124, Catania, Italy


Fibrolamellar hepatocellular carcinoma (FLH) is a rare variant of hepatocellular carcinoma that typically occurs in adolescents or young subjects in an otherwise normal liver. Correct recognition of FLH is extremely important, because a complete resection of the tumor can confer an excellent prognosis. FLHs can become large, exerting mass effects on adjacent organs before diagnosis. Unfortunately, there are very few imaging reports describing external compression of the stomach caused by a FLH. We report the case of a young female suffering from dyspepsia and abdominal pain caused by stomach compression resulting from a large FLH.

If the inline PDF is not rendering correctly, you can download the PDF file here.

  • [1] Craig J. R., Peters R.L., Edmondson H.A., Omata M., Fibrolamellar carcinoma of the liver: a tumor of adolescents and young adults with distinctive clinicopathologic features, Cancer, 1980, 46, 372–379<372::AID-CNCR2820460227>3.0.CO;2-S

  • [2] Ichikawa T., Federle M.P., Grazioli L., Marsh W., Fibrolamellar hepatocellular carcinoma: pre- and posttherapy evaluation with CT and MR imaging, Radiology, 2000, 217, 145–151

  • [3] Ichikawa T., Federle M.P., Grazioli L., Madariaga J., Nalesnik M., Marsh W., Fibrolamellar hepatocellular carcinoma: imaging and pathologic findings in 31 recent cases, Radiology, 1999, 213, 352–361

  • [4] Berman M.A., Burnham J.A., Sheahan D.G., Fibrolamellar carcinoma of the liver: an immunohistochemical study of nineteen cases and a review of the literature, Hum. Pathol., 1988, 19, 784–794

  • [5] Liu S., Chan K.W., Wang B., Qiao L., Fibrolamellar hepatocellular carcinoma, Am. J. Gastroenterol., 2009, 104, 2617–2624

  • [6] Bosch F.X., Ribes J., Cléries R., Díaz M., Epidemiology of hepatocellular carcinoma, Clin. Liver Dis., 2005, 9, 191–211

  • [7] Uccello M., Malaguarnera G., Pelligra E.M., Biondi A., Basile F., Motta M., Lipoprotein(a) as a potential marker of residual liver function in hepatocellular carcinoma, Indian J. Med. Paediatr. Oncol., 2011, 32, 71–75

  • [8] Arista-Nasr J., Gutierrez-Villalobos L., Nuncio J., Maldonaldo H., Bornstein-Quevedo L., Fibrolamellar hepatocellular carcinoma in mexican patients, Pathol. Oncol. Res., 2002, 8, 133–137

  • [9] Blachar A., Federle M.P., Ferris J.V., Lacomis J.M., Waltz J.S., Armfield D.R., et al., Radiologists’ performance in the diagnosis of liver tumors with central scars by using specific CT criteria, Radiology, 2002, 223, 532–539

  • [10] Bogdanov M., Perisic M., Jurisic V., Stojacic-Djenic S., Kerkez M.M., Ultrasonographic examination of the liver circulation in patients with liver metastasis from colorectal cancer, J BUON, 2010, 15, 378–381

  • [11] Chen T.K., Wu C.H., Lee C.L., Lai Y.C., Yang S.S., Tu T.C., Endoscopic ultrasonography to study the causes of extragastric compression mimicking gastric submucosal tumor, J. Formos. Med. Assoc., 2001, 100, 758–761


Journal + Issues